ritanserin has been researched along with Hypercapnia in 2 studies
Ritanserin: A selective and potent serotonin-2 antagonist that is effective in the treatment of a variety of syndromes related to anxiety and depression. The drug also improves the subjective quality of sleep and decreases portal pressure.
ritanserin : A thiazolopyrimidine that is 5H-[1,3]thiazolo[3,2-a]pyrimidin-5-one which is substituted at position 7 by a methyl group and at position 6 by a 2-{4-[bis(4-fluorophenyl)methylidene]piperidin-1-yl}ethyl group. A potent and long-acting seratonin (5-hydroxytryptamine, 5-HT) antagonist of the subtype 5-HT2 (Ki = 0.39 nM), it is used in the treatment of a variety of disorders including anxiety, depression and schizophrenia. It has little sedative action.
Hypercapnia: A clinical manifestation of abnormal increase in the amount of carbon dioxide in arterial blood.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To elucidate the role of serotonin in the maintenance of normal breathing and upper airway (UA) patency in obesity, we studied the effects of systemic administration of ritanserin, a serotonin (5-HT) 2A and 2C receptor antagonist, on ventilation (V E) during room air breathing and during hypoxic (10% O2) and hypercapnic (4% CO2) ventilatory challenges in awake young (6-8 wk) and older (7-8 mo) obese and lean Zucker (Z) rats." | 3.71 | Serotonergic modulation of ventilation and upper airway stability in obese Zucker rats. ( Farkas, GA; Krasney, JA; Lee, SD; Magalang, UJ; Nakano, H, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Negri, L | 1 |
| Lattanzi, R | 1 |
| Tabacco, F | 1 |
| Melchiorri, P | 1 |
| Nakano, H | 1 |
| Magalang, UJ | 1 |
| Lee, SD | 1 |
| Krasney, JA | 1 |
| Farkas, GA | 1 |
2 other studies available for ritanserin and Hypercapnia
| Article | Year |
|---|---|
Respiratory and cardiovascular effects of the mu-opioid receptor agonist [Lys7]dermorphin in awake rats.
Topics: Analgesia; Animals; Blood Pressure; Hypercapnia; Injections, Intravenous; Injections, Intraventricul | 1998 |
Serotonergic modulation of ventilation and upper airway stability in obese Zucker rats.
Topics: Age Factors; Analysis of Variance; Animals; Hypercapnia; Hyperoxia; Linear Models; Obesity; Plethysm | 2001 |